Demirci, N. S. Et Al. 2017. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study. Current Medical Research and Opinion , vol.33, no.3 , 401-407.

Demirci, N. S., Aksoy, S., Özdemir, N. Y., Erdem, G. U., Ozcelik, M., Tanrikulu, E., ... Eren, T.(2017). Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study. Current Medical Research and Opinion , vol.33, no.3, 401-407.

Demirci, Nebi Et Al. "Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study," Current Medical Research and Opinion , vol.33, no.3, 401-407, 2017

Demirci, Nebi S. Et Al. "Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study." Current Medical Research and Opinion , vol.33, no.3, pp.401-407, 2017

Demirci, N. S. Et Al. (2017) . "Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study." Current Medical Research and Opinion , vol.33, no.3, pp.401-407.

@article{article, author={Nebi Serkan Demirci Et Al. }, title={Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study}, journal={Current Medical Research and Opinion}, year=2017, pages={401-407} }